학술논문

PGC-1s in the Spotlight with Parkinson's Disease.
Document Type
Article
Source
International Journal of Molecular Sciences. Apr2021, Vol. 22 Issue 7, p3487. 1p.
Subject
*PARKINSON'S disease
*PEROXISOME proliferator-activated receptors
*DOPAMINERGIC neurons
*SUBSTANTIA nigra
*NEURODEGENERATION
*QUALITY control
Language
ISSN
1661-6596
Abstract
Parkinson's disease is one of the most common neurodegenerative disorders worldwide, characterized by a progressive loss of dopaminergic neurons mainly localized in the substantia nigra pars compacta. In recent years, the detailed analyses of both genetic and idiopathic forms of the disease have led to a better understanding of the molecular and cellular pathways involved in PD, pointing to the centrality of mitochondrial dysfunctions in the pathogenic process. Failure of mitochondrial quality control is now considered a hallmark of the disease. The peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) family acts as a master regulator of mitochondrial biogenesis. Therefore, keeping PGC-1 level in a proper range is fundamental to guarantee functional neurons. Here we review the major findings that tightly bond PD and PGC-1s, raising important points that might lead to future investigations. [ABSTRACT FROM AUTHOR]